TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 87 filers reported holding TG THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 3.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $781,969 | -67.2% | 93,537 | -2.5% | 0.00% | 0.0% |
| Q2 2023 | $2,383,348 | +26.4% | 95,948 | -23.5% | 0.00% | 0.0% |
| Q1 2023 | $1,885,475 | +59.0% | 125,364 | +25.1% | 0.00% | 0.0% |
| Q4 2022 | $1,185,555 | +114.0% | 100,216 | +7.0% | 0.00% | – |
| Q3 2022 | $554,000 | +35.5% | 93,628 | -2.9% | 0.00% | – |
| Q2 2022 | $409,000 | -46.9% | 96,412 | +19.1% | 0.00% | – |
| Q1 2022 | $770,000 | -75.7% | 80,957 | -51.5% | 0.00% | -100.0% |
| Q4 2021 | $3,175,000 | -43.8% | 167,091 | -1.5% | 0.00% | -66.7% |
| Q3 2021 | $5,647,000 | -11.9% | 169,662 | +2.7% | 0.00% | 0.0% |
| Q2 2021 | $6,410,000 | -18.9% | 165,228 | +0.8% | 0.00% | -25.0% |
| Q1 2021 | $7,903,000 | +32.0% | 163,966 | +42.5% | 0.00% | 0.0% |
| Q4 2020 | $5,985,000 | +182.8% | 115,070 | +45.5% | 0.00% | +300.0% |
| Q3 2020 | $2,116,000 | +65.1% | 79,070 | +20.1% | 0.00% | 0.0% |
| Q2 2020 | $1,282,000 | +39.5% | 65,841 | -29.4% | 0.00% | 0.0% |
| Q1 2020 | $919,000 | -16.4% | 93,302 | -5.9% | 0.00% | 0.0% |
| Q4 2019 | $1,099,000 | +60.0% | 99,115 | -19.2% | 0.00% | – |
| Q3 2019 | $687,000 | -35.7% | 122,602 | -0.8% | 0.00% | -100.0% |
| Q2 2019 | $1,068,000 | +103.4% | 123,561 | +88.8% | 0.00% | – |
| Q1 2019 | $525,000 | -84.5% | 65,440 | -92.1% | 0.00% | -100.0% |
| Q4 2018 | $3,378,000 | -47.9% | 824,164 | -28.8% | 0.00% | 0.0% |
| Q3 2018 | $6,480,000 | +132.8% | 1,157,397 | +446.7% | 0.00% | +100.0% |
| Q2 2018 | $2,783,000 | +5.6% | 211,705 | +13.9% | 0.00% | 0.0% |
| Q1 2018 | $2,636,000 | +173.2% | 185,798 | +57.5% | 0.00% | 0.0% |
| Q4 2017 | $965,000 | +26.8% | 117,990 | +83.5% | 0.00% | 0.0% |
| Q3 2017 | $761,000 | -10.5% | 64,306 | -24.1% | 0.00% | 0.0% |
| Q2 2017 | $850,000 | +474.3% | 84,706 | +562.1% | 0.00% | – |
| Q1 2017 | $148,000 | +15.6% | 12,794 | -53.9% | 0.00% | – |
| Q4 2016 | $128,000 | -35.0% | 27,752 | +8.1% | 0.00% | – |
| Q3 2016 | $197,000 | -50.4% | 25,680 | -61.0% | 0.00% | – |
| Q2 2016 | $397,000 | -13.7% | 65,776 | +21.6% | 0.00% | – |
| Q1 2016 | $460,000 | -32.6% | 54,088 | -5.4% | 0.00% | – |
| Q4 2015 | $682,000 | -55.4% | 57,190 | -62.3% | 0.00% | -100.0% |
| Q3 2015 | $1,530,000 | +10.6% | 151,844 | +82.0% | 0.00% | 0.0% |
| Q2 2015 | $1,383,000 | -28.2% | 83,443 | -33.0% | 0.00% | 0.0% |
| Q1 2015 | $1,926,000 | +66.8% | 124,517 | +70.6% | 0.00% | 0.0% |
| Q4 2014 | $1,155,000 | +98.5% | 72,989 | +33.5% | 0.00% | – |
| Q3 2014 | $582,000 | +13.9% | 54,669 | +0.2% | 0.00% | – |
| Q2 2014 | $511,000 | +153.0% | 54,560 | +85.3% | 0.00% | – |
| Q1 2014 | $202,000 | -1.9% | 29,440 | -44.5% | 0.00% | – |
| Q4 2013 | $206,000 | +123.9% | 53,010 | +186.2% | 0.00% | – |
| Q3 2013 | $92,000 | – | 18,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |